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Gastrointestinal infections by Salmonella enterica serovar Typhi (S. Typhi) are rare in 
industrialized countries. However, they remain a major public health problem in the 
developing world with an estimated 26.9 million new cases annually and significant 
mortality when untreated. Recently, we provided the first direct evidence that CD8+ 
MAIT cells are activated and have the potential to kill cells exposed to S. Typhi, and 
that these responses are dependent on bacterial load. However, MAIT cell kinetics and 
function during bacterial infections in humans remain largely unknown. In this study, 
we characterize the human CD8+ MAIT cell immune response to S. Typhi infection in 
subjects participating in a challenge clinical trial who received a low- or high dose of 
wild-type S. Typhi. We define the kinetics of CD8+ MAIT cells as well as their levels of 
activation, proliferation, exhaustion/apoptosis, and homing potential. Regardless of the 
dose, in volunteers resistant to infection (NoTD), the levels of CD8+ MAIT cells after S. 
Typhi challenge fluctuated around their baseline values (day 0). In contrast, volunteers 
susceptible to the development of typhoid disease (TD) exhibited a sharp decline in 
circulating MAIT cells during the development of typhoid fever. Interestingly, MAIT cells 
from low-dose TD volunteers had higher levels of CD38 coexpressing CCR9, CCR6, 
and Ki67 during the development of typhoid fever than high-dose TD volunteers. No 
substantial perturbations on the levels of these markers were observed in NoTD vol-
unteers irrespective of the dose. In sum, we describe, for the first time, that exposure 
to an enteric bacterium, in this case S. Typhi, results in changes in MAIT cell activation, 
proliferation, and homing characteristics, suggesting that MAIT cells are an important 
component of the human host response to bacterial infection.
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Figure 1 | Kinetics of MaiT cells over a 28-day post-challenge follow-up period. Ex vivo peripheral blood mononuclear cells were stained with YEVID, 
followed by surface staining with monoclonal antibodies to CD3, CD4, CD8, CD14, CD19, CD161, and TCRα 7.2 and analyzed by multichromatic flow cytometry. 
For the analysis, following the elimination of doublets and other debris, the cells were gated on lymphocytes, and then a “dump” channel was used to eliminate dead 
cells (YEVID+) as well as macrophages (CD14+), and B cells (CD19+) from the analyses. This was followed by additional gating on CD3, CD4, and CD8, as well as 
CD161 vs. TCRα 7.2 to analyze MAIT cells. (a) A representative gating strategy for MAIT cells. (B) Individual volunteers and (c) combined data of MAIT cell kinetics. 
Bar graphs extend from the 25th to 75th percentiles, and the line in the middle represents the median of the pooled data from all the volunteers. The whiskers 
delineate the smallest to the largest value. Numbers in the “X” axis represent days after the challenge, except for the numbers inside of the green box that represent 
48 and 96 h after diagnosis of typhoid disease. NoTD, volunteers who did not develop typhoid disease; TD, volunteers who developed typhoid disease.
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inTrODucTiOn
MAIT cells are an “innate” like population of T cells that display 
a TCR Vα7.2+CD161+ phenotype and are restricted by the non-
classical MHC-related molecule 1 (MR1) (1–3). While thymic 
MAIT cells have the ability to respond to bacterial stimulation by 
upregulating activation (CD127) and proliferation (Ki67) mark-
ers, their cell surface phenotype is similar to that of naïve T cells 
(4, 5). After birth, MAIT cells acquire a memory phenotype and 
expand dramatically in the mucosa and periphery. MAIT cells are 
few and naive in cord blood (6) but constitute up to 10% of human 
blood T  cells in adults (7), making their biology and behavior 
relatively easy to study in ex vivo assays. Human MAIT cells also 
express molecules such as CD26, CD45RO, and transcription 
factors RORγt and ZBTB16, which are involved in their function 
(7–10). Moreover, they express on their cell surface high levels 
of cytokine receptors for IL-18, IL-12, and IL-23 (6, 7) and can 
secrete TNF-α, IFN-γ, IL-17, granzyme a/b, and perforin (3, 7, 11, 
12), the latter reinforcing their cytotoxic capability. MAIT cells can 
also harbor strong immune responses to various bacteria includ-
ing gut commensals and pathogens from the Enterobacteriaceae 
family (e.g., Salmonella) (12). Recently, we provided the first 
direct evidence that CD8+ MAIT  cells are activated, able to 
secrete cytokines and exhibit cytotoxic properties against B cells 
exposed to gut commensals and pathogens such as Salmonella 
enterica serovar Typhi (S. Typhi) (12). These responses were MR1 
restricted and involved the endocytic pathway. Moreover, the 
quality of these responses (i.e., cytokine profiles) was dependent 
on bacterial load, but not on the level of expression of MR1 or 
bacterial antigen on B cell surfaces (12). Thus, the evaluation of 
the influence of the bacterial load in CD8+ MAIT cell kinetics 
may provide further insight of the CD8+ MAIT cell role during 
bacterial infection.
Challenge studies in which healthy adult volunteers are 
intentionally infected with wild-type pathogens to test drugs and 
vaccines are a particularly relevant model for Salmonella infec-
tion. In the 1950s and 1970s, Dr. Theodore E. Woodward and 
Dr. Myron M. Levine of the University of Maryland in Baltimore 
conducted challenge studies with S. Typhi that led to the use of 
chloramphenicol in the treatment of patients with typhoid fever 
(13) and helped speed up the development of the Ty21a typhoid 
vaccine (14), the only oral live-attenuated vaccine licensed in 
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Figure 2 | continued
Figure 2 | continued  
MaiT cell activation following Salmonella enterica serovar Typhi challenge. Ex vivo peripheral blood mononuclear cells were analyzed as described in 
Figure 1. Expression of CD38 and HLA-DR was evaluated to identify activated MAIT cells. Activated MAIT cells in individual volunteers expressing (a) CD38 or 
coexpressing (B) CD38 and HLA-DR surface markers. (c) Combined data of the activated MAIT cells coexpressing CD38 and HLA-DR surface markers in all 
volunteers. (D) Representative data of MAIT cells coexpressing CD38 and HLA-DR surface markers within the CD3+CD4−CD8+ T cell population. Bar graphs extend 
from the 25th to 75th percentiles, and the line in the middle represents the median of the pooled data from the five different subjects. The whiskers delineate the 
smallest to the largest value. Numbers in the “X” axis represent days after the challenge, except for the numbers inside of the green box that represent 48 and 96 h 
after diagnosis of typhoid disease. NoTD, volunteers who did not develop typhoid disease; TD, volunteers who developed typhoid disease.
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the US (15). More recently, Dr. Pollard’s group [Oxford Vaccine 
Group (OVG), UK] has shown that by using smaller inoculums 
of virulent S. Typhi [~103 or ~104 colony-forming units (CFU)] 
administered following ingestion of a bicarbonate solution, the 
challenge can be performed safely, with attack rates in excess 
of 50% (14). In a previous study (12), we evaluated the impact 
of bacterial load on the restimulation of a “pre-formed pool” of 
CD8+ MAIT cells. The present studies extend these observations 
by studying CD8+ MAIT cell expansion and/or burst size in vivo 
after exposure to different S. Typhi bacterial loads. Using cells 
from volunteers participating in an Oxford challenge study who 
received a low- or high dose of wild-type S. Typhi, we investigated 
the ex vivo kinetics of CD8+ MAIT cell responses for up to 28 days 
after the challenge. We also defined CD8+ MAIT cell proliferation 
(Ki67), activation (CD38 and HLA-DR), exhaustion/apoptosis 
(CD57, caspase-3), and homing (CCR9 and CCR6) markers in 
mediating these responses. Regardless of the dose, in volunteers 
resistant to the infection (NoTD), the levels of CD8+MAIT cells 
after S. Typhi challenge fluctuated around their baseline values 
(day 0). In contrast, in volunteers susceptible to the develop-
ment of typhoid disease (TD) we observed a sharp decline in 
circulating CD8+ MAIT cells during the development of typhoid 
fever. Interestingly, we found that TD volunteers exposed to low 
doses of wild-type S. Typhi (103 CFU) had higher levels of CD8+ 
MAIT cells coexpressing CD38 and either CCR9, CCR6, or Ki67 
during the development of typhoid fever than TD volunteers 
receiving a high dose of S. Typhi (104 CFU).
In sum, we describe, for the first time, that exposure to an 
enteric bacterium, in this case S. Typhi, results in changes in 
MAIT cell activation, proliferation, and homing characteristics. 
These results suggest that MAIT cells are an important compo-
nent of the human host response to bacterial infection.
MaTerials anD MeThODs
subjects
Healthy volunteers, between 18 and 60 years old, were screened 
for good health by medical history, physical examination, and 
normal laboratory tests, including blood counts. Individuals 
who previously received typhoid vaccination or have a residence 
for >6  months in typhoid-endemic areas were not eligible to 
participate in the study. A 2-week course of antibiotic treatment 
was initiated if typhoid diagnosis occurred (temperature ≥38°C 
sustained ≥12 h or bacteremia) or at day 14 post-challenge for 
the volunteers who did not develop typhoid fever (14). Twenty 
volunteers, 10 volunteers who received high (104 CFU) and 10 
volunteers who received low (103  CFU) dose of the S. Typhi 
inoculum, and whose peripheral blood mononuclear cells 
(PBMC) were available were selected for the studies described 
in this manuscript (Table S1 in Supplementary Material). High- 
and low-dose inoculum groups were composed of volunteers 
who developed TD or not (Table S1 in Supplementary Material). 
Time points selected for the studies described in this manuscript 
included before and up to 28  days after the challenge. PBMC 
isolated from these volunteers were studied ex vivo without any 
in vitro stimulation.
antibodies and cell culture Media
Cells were surface stained with anti-human monoclonal antibod-
ies (mAbs) to CD3 (clone OKT3), CD14 (clone M5E2), CD19 
(clone HIB19), CD161 (clone HP-3G10), TCR Vα7.2 (clone 
3C10) (Biolegend, San Diego, CA, USA), CD4 (clone L200), 
CD8 (clone SK1), activated caspase-3 (clone C92-605), CCR6 
(clone 11A9), HLA-DR (clone G46-6), Ki67 (clone B56) (BD 
Pharmingen, San Diego, CA, USA), CCR9 (clone 112509) (R&D, 
Minneapolis, MN, USA), CD38 (clone LS198.4.3) (Beckman-
Coulter, Miami, FL, USA), and CD57 [clone TB01 (TB01); 
eBioscience, San Diego, CA, USA]. Antibodies conjugated to the 
following fluorochromes were used in these studies: fluorescein 
isothiocyanate (FITC), phycoerythrin (PE), peridinin chlorophyll 
protein (PerCP)-Cy5.5, PE-Cy7, energy coupled dye or PE-Texas-
red conjugate (ECD), violet (V) 450 (e.g., similar to Pacific blue), 
brilliant violet (BV) 570, BV605, BV650, quantum dot (QD) 800, 
Alexa 647, allophycocyanin (APC)-Alexa 700 and APC-H7.
Culture medium consisted of RPMI 1640 (Gibco, Grand 
Island, NY, USA) supplemented with 100 U/ml penicillin, 100 µg/
ml streptomycin, 50  µg/ml gentamicin, 2  mM l-glutamine, 
2.5 mM sodium pyruvate, 10 mM HEPES buffer, and 10% heat-
inactivated fetal bovine serum (R10).
surface and intracellular staining
Ex vivo PBMC were used for this experiment. Briefly, after over-
night (16–18 h) resting at 37°C, 5% CO2, PBMC were harvested, 
stained with a dead-cell discriminator, yellow fluorescent viability 
dye (YEVID, Invitrogen, Carlsbad, CA, USA) (16), followed by 
surface staining with mAbs against caspase-3, CCR6, CCR9, CD3, 
CD4, CD8, CD14, CD19, CD38, CD57, CD161, HLA-DR, and 
TCRα 7.2 surface antigens and fixation and permeabilization with 
Fix & Perm cell buffers (Invitrogen, Carlsbad, CA, USA) (12, 16). 
Cells were then stained intracellularly for Ki67. Finally, cells were 
resuspended in fixation buffer (1% formaldehyde) and analyzed 
as soon as possible by flow cytometry on an LSR-II instrument 
(BD Biosciences). Data were analyzed with WinList v6.0 (Verity 
Software House, Topsham, ME, USA). Lymphocytes were gated 
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Figure 3 | continued
Figure 3 | continued  
identification of exhausted and apoptotic MaiT cells following Salmonella enterica serovar Typhi challenge. Ex vivo peripheral blood mononuclear cells 
were analyzed as described in Figure 1. Expression of CD57 and caspase-3 were performed to identify exhausted and apoptotic MAIT cells, respectively. 
Combined data of MAIT cells expressing (a) CD57 or coexpressing (B) CD57 and CD38 surface markers. Combined data of MAIT cells expressing (c) caspase-3 
or coexpressing (D) caspase-3 and CD38 surface markers. Bar graphs extend from the 25th to 75th percentiles, and the line in the middle represents the median of 
the pooled data from the five different subjects. The whiskers delineate the smallest to the largest value. Numbers in the “X” axis represent days after the challenge, 
except for the numbers inside of the green box that represent 48 and 96 h after diagnosis of typhoid disease. NoTD, volunteers who did not develop typhoid 
disease; TD, volunteers who developed typhoid disease.
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based on their scatter characteristics. Single lymphocytes were 
gated based on forward scatter height vs. forward scatter area. 
A “dump” channel was used to eliminate dead cells (YEVID+) 
as well as macrophages/monocytes (CD14+) and B lymphocytes 
(CD19+) from analysis. This was followed by additional gating 
on CD3, CD8, CD161, and TCR Vα7.2 to identify MAIT cells. 
During sample acquisition, routinely 300,000–500,000 events 
were collected in the forward and side scatter lymphocyte gate. 
This large number of gated MAIT  cell events was essential 
to ensure that a sufficient number of positive cells for defined 
subsets would be collected for each tube analyzed.
statistical analysis
All statistical tests were performed using SAS 9.3 (Cary, NC, 
USA). Observations were grouped by day following challenge 
in the following periods: pre-challenge, days 1–4, days 7–9 or 
within 48–96  h of disease onset, and days 14–28. Volunteers 
generally contributed more than one observation to each time 
period. To compare mean values by time period and group, while 
accounting for correlation between multiple measures from the 
same volunteer at the same time period and across time periods, 
we used mixed effects models. These models, which include a 
random effect for the subject, were fit by restricted maximum 
likelihood. Correlations used the Pearson product–moment tests. 
P values <0.05 were considered significant.
resulTs
Kinetics of MaiT cells over a 28-Day 
Post-challenge Follow-up
Because of the potential importance of CD8+ MAIT cells (hence-
forth called MAIT cells) in resistance to bacterial infection, in par-
ticular to Salmonella infection (12), we investigated their kinetics 
in subjects participating in a dose-escalation challenge clinical 
trial conducted by Dr. Pollard’s group (Oxford Vaccine Group) 
(14). This study was performed using the antibiotic susceptible, 
virulent wild-type S. Typhi Quailes strain, which was first isolated 
in 1958 from the gallbladder of a known chronic carrier (14, 15, 
17). Two separate cohorts were recruited, with one cohort receiv-
ing high (~104 CFU) and another one receiving low (~103 CFU) 
dose of the S. Typhi inoculum. The characteristics of the volunteers 
used for the studies presented in this manuscript are included in 
the Table S1 in Supplementary Material. Based on our previous 
data showing that S. Typhi-specific CD8+ T cell responses can be 
detected as early as 4 days after typhoid fever immunization (18, 
19) or challenge with S. Typhi (20), we hypothesized that changes 
in MAIT cell kinetics might be seen at even earlier time points 
(e.g., days 1 and 2) after the challenge. Innate-like T cells such as 
MAIT cells are known to respond very rapidly (<2 h) after activa-
tion and within the first few days postinfection (5, 21). To test 
this hypothesis, ex vivo PBMC collected before and up to 28 days 
after the challenge (including days 1 and 2) were surface stained 
with mAbs to CD3, CD4, CD8, CD14, CD19, CD161, and TCRα 
7.2 and analyzed by multichromatic flow cytometry. MAIT cells 
were defined as CD3+CD4−CD8+TCR Vα7.2+CD161+ cells 
(Figure  1A; Figure S1 in Supplementary Material). We found 
that regardless of the dose, in volunteers resistant to the infec-
tion (NoTD), the levels of MAIT  cells after S. Typhi challenge 
fluctuated around their baseline values (day 0) (Figures  1B,C; 
Figures S2A and S3A in Supplementary Material). In contrast, 
in volunteers susceptible to the development of TD, we observed 
a sharp decline of MAIT cells 48 and 96 h after diagnosis, a time 
frame used to capture the events occurring immediately after 
the development of typhoid fever (Figures  1B,C; Figures S2A, 
S3A, and S4A in Supplementary Material). These results indicate 
that TD affects the kinetics of circulating MAIT cells. Of note, 
it is important to observe that the time to clinical diagnosis of 
typhoid fever was variable among the TD volunteers (i.e., ranging 
6–13 and 6–10 days after the challenge for low- and high-dose 
volunteers, respectively) (Table S1 in Supplementary Material). 
For this reason, to align the time frames in which the various 
volunteers developed TD, we expressed the data as 48 and 96 h 
after typhoid diagnosis.
MaiT cell activation following challenge 
with Wild-type S. Typhi
To further investigate the association between decreases in the 
numbers of circulating MAIT  cells and their functionality, we 
next measured the expression of CD38 and HLA-DR activation 
markers. CD38 and HLA-DR are well-known activation mol-
ecules expressed on the cell surface of activated T cells during the 
acute phase of bacterial and viral infections in humans (22–24). 
Regardless of the dose, we found that challenge elicited increased 
levels of activated MAIT  cells (either CD38+ single positive or 
CD38+HLA-DR+ double positive) in TD volunteers, a phenom-
enon that was associated with the time of TD (48 and 96 h after 
diagnosis of typhoid fever) (Figures  2A–D). Interestingly, the 
magnitude of the activation of CD38+ single positive, but not 
CD38+HLA-DR+ double positive MAIT  cells was significantly 
higher in volunteers in the low-dose cohort than in those in 
the high-dose group (Figure S4B in Supplementary Material). 
Only minimal perturbations on levels of CD38 or HLA-DR-
expressing MAIT  cells were observed in NoTD volunteers 
(Figures 2A–D; Figures S2B and S3B in Supplementary Material). 
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Figure 4 | continued
Figure 4 | continued  
MaiT cell proliferation following Salmonella enterica serovar Typhi challenge. Ex vivo peripheral blood mononuclear cells were analyzed as described in 
Figure 1. Ki67 expression was used to identify proliferating MAIT cells. (a) Representative data of intracellular expression of Ki67+ MAIT cells over a 28-day 
post-challenge follow-up period in NoTD and typhoid disease (TD) volunteers who received a low- or high-dose challenge. (B) Individual and (c) combined data of 
proliferating MAIT cells from volunteers receiving a low-dose challenge. (D) Individual and (e) combined data of proliferating MAIT cells from volunteers receiving a 
high-dose challenge. (F) Individual and (g) combined data of CD38-positive cells gated on proliferating (Ki67+) MAIT cells. Bar graphs extend from the 25th to 75th 
percentiles, and the line in the middle represents the median of the pooled data from the five different subjects. The whiskers delineate the smallest to the largest 
value. Numbers in the “X” axis represent days after the challenge, except for the numbers inside of the green box that represent 48 and 96 h after diagnosis of 
typhoid disease. NoTD, volunteers who did not develop typhoid disease; TD, volunteers who developed typhoid disease.
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Comparisons between the levels of activated MAIT cells (single 
CD38+ or CD38+HLA-DR+) and the levels of total MAIT cells 
(CD3+CD4−CD8+CD161highTCR Vα7.2+) were performed using 
Pearson product–moment correlation. We found an inverse 
correlation between MAIT  cell activation and MAIT  cell 
decline (R2 =  0.1207; P =  0.0004 and R2 =  0.1679; P =  0.0002 
for levels of total MAIT cells vs. either single CD38+ or double 
CD38+HLA-DR+, respectively) (Figure S5 in Supplementary 
Material). Thus, high levels of either CD38+ single positive or 
CD38+HLA-DR+ double positive-activated MAIT cells are asso-
ciated with a decline of MAIT cells in circulation.
MaiT cell exhaustion and apoptosis 
following challenge with Wild-type S. 
Typhi
To provide additional insights into the decline of MAIT cells 
in circulation, we measured the expression of CD57, a mol-
ecule whose expression is associated with cell exhaustion 
(25), and caspase-3, a molecule indicative of apoptosis (26). 
Similar to the expression of CD38 and HLA-DR markers and 
regardless of the dose, we found high levels of MAIT  cells 
expressing CD57 and caspase-3 markers in TD volunteers 
after typhoid fever diagnosis (Figures  3A,C; Figures S6–S9 
in Supplementary Material). No significant differences were 
found in the levels of MAIT cells expressing either CD57 or 
caspase-3 between the high-dose and low-dose groups (Figure 
S10 in Supplementary Material). We also observed that the 
majority of the CD57 and caspase-3-expressing MAIT  cells 
from TD participants were activated (Figures 3B,D; Figures 
S8 and S9 in Supplementary Material), and there was a direct 
correlation between the coexpression of CD38+HLA-DR+ 
and CD57+ (R2  =  0.1886; P  =  <  0.0001) and caspase-3+ 
(R2  =  0.1919; P  <  0.0001) surface markers (Figure S11 in 
Supplementary Material). No substantial increases in CD57 or 
caspase-3 markers were observed in NoTD volunteers. These 
findings are consistent with a previously proposed model (27) 
in which MAIT  cells are activated, exhausted, and depleted 
during the early stages of infection.
MaiT cell Proliferation Patterns following 
challenge with S. Typhi
Because a well-described consequence of immune activation is 
cell proliferation, we hypothesized that MAIT cells from TD vol-
unteers might have been more susceptible to activation-induced 
proliferation than MAIT  cells from NoTD volunteers. To test 
this hypothesis, we examined the levels of Ki67 proliferation-
associated antigen on MAIT  cells. We found that regardless 
of the dose, Ki67+ MAIT  cells expanded after the challenge in 
TD volunteers, with sharp increases observed at 48 and 96  h 
after diagnosis of TD (Figures  4A–E; Figures S12A and S13A 
in Supplementary Material). Interestingly, while during the 
development of typhoid fever, the proliferation of CD38-positive 
MAIT cells was significantly higher in low-dose TD volunteers 
than in high-dose TD volunteers (Figures 4F,G; Figure S14B in 
Supplementary Material); no differences between the coexpres-
sion of Ki67 and either caspase or CD57+ were found between the 
high- and low-dose groups (Figures 5A,B; Figures S12B, S13B, 
and S14B in Supplementary Material).
MaiT cell homing Patterns following 
challenge with S. Typhi
An explanation for the lower numbers of activation-dependent 
MAIT cell proliferation detected in the blood of high-dose TD 
volunteers as compared with low-dose TD volunteers is that the 
MAIT cells from the former volunteers home earlier and/or at 
higher levels to other compartments in the host (e.g., gut and 
inflamed tissues). To address this possibility, we measured the 
expression of CCR9 and CCR6 molecules, which are involved in 
the homing of cells to the gut and inflamed tissues, respectively. 
We found that, during typhoid fever, although the frequencies 
of CD38+-activated MAIT cells expressing CCR6 or CCR9 hom-
ing markers were increased in all TD volunteers (regardless of 
the dose), their expression levels in the high-dose group were 
significantly lower than those observed in TD volunteers from 
the low-dose group (Figures 6A,B; Figures S6, S7, and S15–S17 in 
Supplementary Material). Moreover, the magnitude of MAIT cells 
coexpressing CCR6 and CCR9 markers were significantly higher, 
during typhoid fever, in TD volunteers receiving the low-dose 
inoculum than in TD volunteers receiving the high-dose inocu-
lum (Figure 6C; Figures S6, S7, and S15–S17 in Supplementary 
Material). We also noted that the frequencies of CD38-positive 
MAIT cells expressing either CCR6 or CCR9 homing molecules 
remain unchanged in NoTD from both high- and low-dose 
groups (Figures  6A,B). Thus, the exposure to higher numbers 
of organisms might affect the homing of MAIT cells to inflamed 
tissues. To evaluate this possibility, we measured the presence of 
MAIT  cells coexpressing caspase-3 and either CCR6 or CCR9 
markers. We found that, although MAIT  cells coexpressing 
caspase-3 and either CCR6 or CCR9 markers were significantly 
higher in TD (during typhoid fever) than in NoTD (7–9 days after 
challenge) volunteers, no significant differences were observed 
when comparing low- and high-dose TD volunteers at 48–96 h 
(Figures  6D,E; Figure S18 in Supplementary Material). The 
differences between TD and NoTD volunteers might be due 
Figure 5 | evaluation of exhaustion and apoptosis in proliferating MaiT cells. Ex vivo peripheral blood mononuclear cells were analyzed as described in 
Figure 1. Expression of CD57 and caspase-3 were performed to identify exhausted and apoptotic in proliferating MAIT cells, respectively. Individual and combined 
data of Ki67+ MAIT cells expressing (a) capsase-3 or (B) CD57 surface markers are shown. MAIT cells were sequentially gated on Ki67+ and then on capsase-3 or 
CD57 surface markers. Bar graphs extend from the 25th to 75th percentiles, and the line in the middle represents the median of the pooled data from the five 
different subjects. The whiskers delineate the smallest to the largest value. Numbers in the “X” axis represent days after the challenge, except for the numbers inside 
of the green box that represent 48 and 96 h after diagnosis of typhoid disease. NoTD, volunteers who did not develop typhoid disease; TD, volunteers who 
developed typhoid disease.
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to a disproportionate number of activation-induced proliferat-
ing MAIT  cells undergoing caspase-3-mediated death during 
typhoid fever. On the other hand, the differences between TD 
volunteers receiving high and low doses might result from the 
numbers of MAIT cells recorded in circulation, which are hom-
ing to the inflamed gut, as measured by the expression of gut 
homing molecules.
DiscussiOn
Despite the predicted importance of MAIT  cell responses in 
protection against bacterial infection, very limited data are 
available concerning the time kinetics and characterization of 
these responses following bacterial infection in humans. Here, 
we described for the first time the kinetics of MAIT cells up to 
Figure 6 | evaluation of the homing potential of MaiT cells following Salmonella enterica serovar Typhi challenge. Ex vivo peripheral blood 
mononuclear cells were analyzed as described in Figure 1. Additional gating on CCR6 and CCR9 were performed to identify MAIT cells with the potential to home 
to inflamed and gut tissues, respectively. Combined data of MAIT cells coexpressing (a) CCR6 and CD38, (B) CCR9 and CD38, (c) CCR6 and CCR9, (D) CCR6 
and caspase-3, and (e) CCR9 and caspase-3 surface markers. Bar graphs extend from the 25th to 75th percentiles, and the line in the middle represents the 
median of the pooled data from the five different subjects. The whiskers delineate the smallest to the largest value. Numbers in the “X” axis represent days after the 
challenge, except for the numbers inside of the green box that represent 48 and 96 h after diagnosis of typhoid disease. NoTD, volunteers who did not develop 
typhoid disease; TD, volunteers who developed typhoid disease.
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28  days following oral challenge of volunteers with wild-type 
S. Typhi. We observed that MAIT  cells, possibly because of 
increased exposure in vivo to the microbes or their components, 
are activated, exhausted, and depleted during the infection.
MAIT cells are an important physiological component of the 
bacterial host defense and may also be involved in inflammatory 
disorders (7, 28, 29). In fact, previous studies have demonstrated 
that MAIT cells may play a significant role in Vibrio cholerae (30), 
Mycobacterium tuberculosis (TB) (31), and human immunodefi-
ciency virus (HIV) (27, 32) infections in humans. For example, 
Gold and colleagues have shown that in humans, MAIT cells are 
decreased in the blood of patients with active TB infection (31). 
In other studies, levels of MAIT cells were found to be severely 
reduced in the circulation of patients with HIV-1 infection (27, 32), 
and their decline was associated with the time of diagnosis (27). 
Thus, we hypothesized that upon microbial stimulation by S. 
Typhi, functionally active circulating MAIT cells expressing gut 
migratory patterns might play a role in the S. Typhi infection.
In this manuscript, we reported that the levels of proliferat-
ing MAIT cells from TD volunteers were higher than in NoTD 
volunteers. These differences were not caused by altered levels of 
T-cell subsets at baseline (day 0), since baseline levels of CD3+, 
CD8+, and MAIT cell populations were similar among TD and 
NoTD volunteers (Figure S19 in Supplementary Material). A key 
property of protective immunity is the ability of conventional 
CD8+ T cells to undergo rapid proliferation, so that a large pool 
of memory cells is available to fight the infection (33). After 
birth, MAIT  cells acquire a memory phenotype and expand 
dramatically in the mucosa and periphery (6). Thus, similar to 
conventional CD8+ T cells, MAIT cell expansion is likely to be 
the result of the antigen presentation. Thus, one would expect that 
increased bacterial loads would lead to greater MAIT cell prolif-
eration. However, during typhoid fever, we found higher levels 
of activated (CD38+) proliferating MAIT cells in TD volunteers 
receiving a low dose than in those TD volunteers receiving a high 
dose of the inoculum. Thus, it is reasonable to speculate that this 
phenomenon might be the result of factors such as the initial 
amount of the inoculum and its ability to activate MAIT  cell 
responses. This assumption is based on previous work from our 
group and others showing that the quality of MAIT cell responses 
is dependent on bacterial load (12), and that the accumulation of 
MAIT cells in the mucosa is dependent on the size of the bacte-
rial inoculum (34). Previous observations showing that partial or 
incomplete antigenic activation can induce defects in prolifera-
tion (35) also support this theory. Moreover, previous reports had 
shown that MAIT cells are more susceptible to activation-driven 
apoptosis than conventional T cells (36), and that antigen-driven 
CD8+ T cell proliferation is lower in volunteers exhibiting high 
viral load (37, 38). However, it is not possible to exclude the 
possibility that the differential proliferation might be due to an 
increased level of MAIT cells undergoing apoptosis after being 
infected by S. Typhi. In fact, previous studies from our group have 
shown that S. Typhi readily infects T cells (39) and that heavily S. 
Typhi-infected cells can undergo apoptosis-mediated cell death 
(40, 41).
Our results also suggest that MAIT cells from TD volunteers 
acquire different homing patterns in function of the initial 
bacterial dose. As previously demonstrated in cells isolated 
from blood (7, 32) and colon (42), most MAIT  cells express 
the chemokine receptors CCR6 and CCR9, presumably con-
tributing to their intestinal localization. Here, we report that 
activated (CD38+) MAIT cells coexpressing CCR6 and CCR9 
markers were significantly higher during typhoid fever in 
TD volunteers receiving the low-dose inoculum than in TD 
volunteers receiving the high-dose inoculum. Thus, increases 
of CCR6 and CCR9-positive MAIT  cells coexpressing CD38 
observed in circulation might translate to a lower recruitment 
of MAIT cells to the inflamed intestinal mucosa in volunteers 
receiving the high-dose inoculum. This hypothesis is consist-
ent with recent work showing that MAIT  cell numbers are 
lower in the intestinal mucosa of patients with inflammatory 
bowel disease than in healthy controls (43). However, little is 
known about the initial steps triggering MAIT  cell homing 
to the inflamed tissues. Thus, studies aiming to examine the 
interactions between MAIT cells and antigen-presenting cells 
are needed to define further and characterize the effects of the 
inoculum size on MAIT cell homing behavior.
It is important to note that the investigators are acutely aware 
that the relatively small number of volunteers available for the 
studies presented in this manuscript, largely resulting from the 
limitations inherent in the performance of challenges with wild-
type organisms in humans, is an overall weakness. However, this 
weakness will mainly affect the study if the null hypothesis is not 
rejected. Indeed, the relatively small number of volunteers studied 
did not preclude us from observing strong, statistically significant 
differences between volunteers allocated to the different cohorts. 
Upcoming studies with larger numbers of volunteers are required 
to confirm and expand the findings detailed in this manuscript.
In sum, to the best of our knowledge, this is the first body of 
work to show in humans the kinetics and characteristics of cir-
culating MAIT cells after S. Typhi infection. These observations 
are of particular importance in that they provide direct evidence 
in humans that the exposure to S. Typhi not only alters the levels 
of activation of MAIT cells but also influences their proliferation 
and homing patterns. These findings also argue that MAIT cells 
play an integral role in the immune response against Salmonella 
infection and might help to maintain a balance between healthy 
and disease in the gut microenvironment. Gastrointestinal infec-
tions by S. Typhi are rare in industrialized countries. However, it 
remains a major public health problem in the developing world. 
Control measures such as sanitation, food hygiene, and vaccina-
tion are high priorities.
eThics sTaTeMenT
All blood collection was approved by National Research Ethic 
Service (NRES), Oxfordshire Research Ethics Committee A 
(10/H0604/53). This protocol has been conducted in accordance 
with the ethical standards laid down in the 1964 Declaration 
of Helsinki and the principles of the International Conference 
on Harmonization Good Clinical Practice guidelines (14, 44). 
Volunteers were explained the purpose of this study and gave 
informed, signed consent before the blood draw. All blood speci-
mens were processed within 4 h of the blood draw. PBMC were 
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isolated from the blood by density gradient centrifugation and 
cryopreserved in liquid N2 following standard techniques (14).
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